[1]
Werth, V., Joly, P., Mimouni, D., Maverakis, E., Lahane, P., Gearhart, L., Pordeli, P. and Chen, D. 2020. A Phase III, Randomized, Double-Blind, Controlled Study (PEMPHIX) to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Patients With Pemphigus Vulgaris. SKIN The Journal of Cutaneous Medicine. 4, 1 (Jan. 2020), S26.